期刊文献+

转移性三阴乳腺癌89例临床特点及生存分析 被引量:11

下载PDF
导出
摘要 目的:分析转移性三阴乳腺癌的转移规律、生存情况及局部治疗在转移性三阴乳腺癌中的作用。方法:收集转移性三阴乳腺癌患者89例,81例接受改良根治术,8例接受保乳手术。应用Kaplan-Meier法计算生存率,Logrank法检验进行统计学分析。结果:三阴乳腺癌最常见的转移部位为肺(64.0%)、骨(49.4%)、肝(32.6%)、脑(19.1%),单器官转移25例(28.1%)、多器官转移64例(71.9%),在初诊后3年内转移最多。转移后中位随访时间为68(32~139)个月,随访率为100℅。全组转移后5年总生存率、无进展生存率分别为24.2%、6.7%,中位生存时间25个月。单器官转移、多器官转移5年总生存率分别为57.2%、10.3%(P=0.001)。有局部治疗组和无局部治疗组的5年总生存率分别为39.5%、3.2%(P〈0.001)。结论:转移性三阴乳腺癌常见肺、骨、肝和脑转移;单器官转移预后好于多器官转移,挽救性局部治疗好于无局部治疗。
出处 《陕西医学杂志》 CAS 2016年第7期859-861,共3页 Shaanxi Medical Journal
  • 相关文献

参考文献3

二级参考文献42

  • 1Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001 ) in the Metropolitan Detroit Cancer Surveillance System [ J]. J Clin Oncol, 2004,22 (14) :2865-2872.
  • 2Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer [J]. J Clin Oncol, 2004,22(17) :3608-3617.
  • 3Patanaphan V, Salazar OM, Risco R. Breast cancer : Metastatic patterns and their prognosis [ J]. South Med J, 1985,81(9) :1109-1112.
  • 4Tsukada Y, Fouad A, Pickren JW, et al. Central nervous system metastasis from breast carcinoma. Autopsy study [J]. Cancer, 1983,52(12) :2349-2354.
  • 5Lin NU, Claus E, Sohl J, et al. Sites of Distant recurrence and clinical outcomes in patients with metastatic triple-negative beast cancer [ J ]. Cancer, 2008,113(10) :2638-2645.
  • 6Dawood S, Broglio K, Esteva F J, et al. Survival among women with triple receptor-negative breast cancer and brain metastases [J]. Ann Oncol, 2009,20(4) :621- 627.
  • 7Nam BH, Kim SY, Han HS, et al. Breast cancer subtypes and survival in patients with brain metastases [J]. Breast Cancer Res, 2008,10(1) :R20.
  • 8Gabos Z, Sinha R, Hanson J, et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer [ J]. J Clin Oncol, 2006, 24 (36) : 5658-5663.
  • 9Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) [ J]. Ann Oncol, 2006, 17(6) :935-944.
  • 10Hicks DG, Short SM, Prescott NL, et al. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and over express HER2 or EGFR [ J]. Am J Surg Pathol, 2006,30 (9) : 1097-1104.

共引文献25

同被引文献101

引证文献11

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部